Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor

J Clin Oncol. 2009 Dec 1;27(34):e215-7. doi: 10.1200/JCO.2009.22.4931. Epub 2009 Sep 28.

Authors

Francisco A Perez¹, Corinne L Fligner, Evan Y Yu

Affiliation

¹ Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.

PMID: 19786665
DOI: 10.1200/JCO.2009.22.4931

No abstract available

Publication types

Case Reports

MeSH terms

Carcinoma, Transitional Cell / blood*
Carcinoma, Transitional Cell / secondary
Filgrastim
Granulocyte Colony-Stimulating Factor / adverse effects*
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Leukemoid Reaction / chemically induced*
Leukemoid Reaction / diagnosis
Male
Middle Aged
Neutropenia / drug therapy
Polyethylene Glycols
Recombinant Proteins
Urinary Bladder Neoplasms / blood*
Urinary Bladder Neoplasms / pathology

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
pegfilgrastim
Polyethylene Glycols
Filgrastim